dc.contributor.author | Thaiyah, AG | |
dc.contributor.author | Chege, JN | |
dc.contributor.author | Muriuki, SK | |
dc.contributor.author | Wekesa, LS | |
dc.date.accessioned | 2015-07-10T06:12:53Z | |
dc.date.available | 2015-07-10T06:12:53Z | |
dc.date.issued | 1993 | |
dc.identifier.citation | Bulletin of Animal Health and Production in Africa 1993 Vol. 41 No. 4 pp. 333-335 | en_US |
dc.identifier.uri | http://www.cabdirect.org/abstracts/19940803466.html?resultNumber=4&q=au%3A%22Muriuki%2C+S.+K.%22 | |
dc.identifier.uri | http://hdl.handle.net/11295/87040 | |
dc.description.abstract | A retrospective study of 24 cattle in the Kabete area, Kenya, which had been treated for East Coast Fever with buparvaquone (2.5 mg/kg) showed that 5 of the animals recovered after a single dose, and 10 recovered after a single dose buparvaquone combined with one or more of oxytetracycline, Vetbenzamine and Catasol. Of 4 animals given 2 doses of buparvaquone at an interval of 48 h, only 2 recovered. 2 animals recovered after one dose of buparvaquone followed after 48 h by 1 dose of halofuginone (1.5 mg/kg). The overall survival rate with buparvaquone was 79.2% | en_US |
dc.language.iso | en | en_US |
dc.publisher | University of Nairobi | en_US |
dc.title | Efficacy of buparvaquone in the treatment of ECF cases in the Kabete area of Kiambu district of Kenya: preliminary results. | en_US |
dc.type | Article | en_US |
dc.type.material | en | en_US |